Effectiveness of relapsing multiple sclerosis patients switching to teriflunomide following disease progression in a real-world setting

被引：0
|
作者：
Miravalle, A. [1 ]
Greene, N. [2 ]
Miller, R. [1 ]
Miller, T. [1 ]
Olson, J. M. [1 ]
Reddy, S. R. [3 ]
Chang, E. [3 ]
Fadaee, S. [2 ]
McGuey, L. [2 ]
Quach, C. [2 ]
Lublin, A. [2 ]
机构：
[1] Rockies LLC, Multiple Sclerosis Ctr, Ft Collins, CO USA
[2] Sanofi Genzyme, Cambridge, MA USA
[3] PHAR LLC, Beverly Hills, CA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P858
引用
收藏
页码：705 / 705
页数：1
相关论文
共 50 条
  • [1] Effectiveness and safety of switching to teriflunomide in older patients with relapsing multiple sclerosis: a real-world multicenter analysis
    Berkovich, R.
    Negroski, D.
    Wynn, D.
    Bzdek, K.
    Lublin, A.
    Quach, C.
    Wells, D.
    Bora, A.
    Ranno, A.
    Dumlao, M.
    Luo, K. Lin
    Rawlings, A.
    Chavin, J.
    Hua, L. H.
    Becker, D.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 54 - 55
  • [2] Effectiveness and safety of switching to teriflunomide in older patients with relapsing multiple sclerosis: A real-world retrospective multicenter analysis
    Berkovich, Regina
    Negroski, Donald
    Wynn, Daniel
    Sellers, Daniel
    Bzdek, Kristen G.
    Lublin, Alex L.
    Rawlings, Andreea M.
    Quach, Cuc
    Wells, Danelle P.
    Dumlao, Melanie
    Bora, Adriana
    Ranno, Anthony E.
    Luo, Kevin Lin
    Chavin, Jeffrey
    Hua, Le H.
    Becker, Daniel
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 70
  • [3] Teriflunomide for multiple sclerosis in real-world setting
    Elkjaer, M. L.
    Molnar, T.
    Illes, Z.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (05): : 447 - 453
  • [4] Real-World Effectiveness of Disease-Modifying Therapies in Korean Patients with Relapsing Multiple Sclerosis
    Kim, Su-Hyun
    Park, Min Su
    Kim, Woojun
    Huh, So-Young
    Shin, Hyun-June
    Hyun, Jae-Won
    Kim, Ho Jin
    JOURNAL OF CLINICAL NEUROLOGY, 2019, 15 (01): : 20 - 26
  • [5] Real-world outcomes of teriflunomide in relapsing–remitting multiple sclerosis: a prospective cohort study
    Yao Zhang
    Hexiang Yin
    Dingding Zhang
    Yan Xu
    Bin Peng
    Liying Cui
    Journal of Neurology, 2022, 269 : 4808 - 4816
  • [6] Efficacy, tolerability and safety of teriflunomide in multiple sclerosis in a real-world clinical setting
    Oreja-Guevara, C.
    Orviz-Garcia, A.
    Guerra-Schulz, E.
    Lopez de Velasco, V.
    Lopez-Perez, F.
    Palacios, M.
    Gonzalez-Suarez, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 544 - 544
  • [7] Real-world effectiveness of natalizumab treatment in patients with relapsing multiple sclerosis in Argentina and Chile
    Ysrraelit, Maria Celica
    Caride, Alejandro
    Sinay, Vladimiro
    Rivera Kindel, Mario
    Halfon, Mario Javier
    Patrucco, Liliana
    Piedrabuena, Raul
    Diaz Aragunde, Vanina Eleonor
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2021, 79 (05) : 407 - 414
  • [8] Real-world outcomes of teriflunomide in relapsing-remitting multiple sclerosis: a prospective cohort study
    Zhang, Yao
    Yin, Hexiang
    Zhang, Dingding
    Xu, Yan
    Peng, Bin
    Cui, Liying
    JOURNAL OF NEUROLOGY, 2022, 269 (09) : 4808 - 4816
  • [9] Real-world outcomes of teriflunomide in relapsing-remitting multiple sclerosis: a prospective cohort study
    Zhang, Y.
    Yin, H.
    Zhang, D.
    Xu, Y.
    Peng, B.
    Cui, L.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 888 - 889
  • [10] Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis
    Boz, C.
    Ozakbas, S.
    Terzi, M.
    Turkoglu, R.
    Akman, G.
    Efendi, H.
    Akcali, A.
    Tuncer, A.
    Yuceyar, N.
    Turan, O. F.
    Soysal, A.
    Koseoglu, M.
    Balci, B. P.
    Sevim, S.
    Altintas, A.
    Cilingir, V.
    Demirkiran, M.
    Kizilay, F.
    Altunrende, B.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 327 - 328
12345